T1	Participants 342 366	241 consecutive patients
T2	Participants 448 461	three groups.
T3	Participants 474 480	Group1
T4	Participants 713 720	Group 2
T5	Participants 1003 1010	Group 3
T6	Participants 1231 1238	Group 1
T7	Participants 1208 1219	13 patients
T8	Participants 1240 1252	six patients
T9	Participants 1298 1305	Group 3
T10	Participants 1275 1286	31 patients
T11	Participants 1263 1270	Group 2
